Catalogo dei prodotti della ricerca

ADDUCI, CARMEN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.214
EU - Europa 520
AS - Asia 163
AF - Africa 19
SA - Sud America 5
Totale 1.921
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.205
DE - Germania 216
IT - Italia 123
IN - India 63
SG - Singapore 46
CN - Cina 41
IE - Irlanda 37
SE - Svezia 30
BG - Bulgaria 27
AT - Austria 23
FI - Finlandia 20
TG - Togo 18
RO - Romania 13
TR - Turchia 9
GB - Regno Unito 7
UA - Ucraina 7
FR - Francia 6
CA - Canada 5
MX - Messico 4
RS - Serbia 4
RU - Federazione Russa 4
AR - Argentina 2
BR - Brasile 2
JO - Giordania 2
PK - Pakistan 2
BY - Bielorussia 1
CL - Cile 1
LV - Lettonia 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 1.921
Salva come PNG Salva come JPEG
Città #
Fairfield 201
Ashburn 106
Woodbridge 105
Seattle 94
Cambridge 84
Chandler 79
Houston 73
Wilmington 73
Rome 49
Princeton 38
Ann Arbor 27
Beijing 27
Sofia 27
San Paolo di Civitate 26
Lawrence 25
Plano 25
Singapore 25
Dublin 24
Dearborn 21
Vienna 20
Lomé 18
San Diego 17
New York 16
Millbury 15
Boston 13
Andover 10
Milan 9
Fremont 5
Helsinki 5
Istanbul 5
Norwalk 5
Pune 5
Des Moines 3
Menlo Park 3
Oxford 3
Siracusa 3
Toronto 3
Ankara 2
Bühl 2
Cantalupo in Sabina 2
Chongqing 2
Falls Church 2
Federal 2
Galati 2
Hefei 2
Kunming 2
Lahore 2
London 2
Ottawa 2
Romainville 2
Vidin 2
Adana 1
Bari 1
Basking Ridge 1
Buffalo 1
Chengdu 1
Dallas 1
Davis 1
Elista 1
Formigine 1
Frankfurt am Main 1
Fuzhou 1
Genova 1
Hanover 1
Hyderabad 1
Imola 1
Irkutsk 1
Jacksonville 1
Jinan 1
Jinhua 1
Lappeenranta 1
Leawood 1
Lissone 1
Los Angeles 1
Mannheim 1
Marano Di Napoli 1
Mexico City 1
Minsk 1
Munich 1
Phoenix 1
Portici 1
Provo 1
Redwood City 1
San Pablo 1
Santiago 1
Silverton 1
Springfield 1
São Paulo 1
Targu Jiu 1
Torino 1
Wandsworth 1
Washington 1
Wenzhou 1
Wuhan 1
Xian 1
Totale 1.359
Salva come PNG Salva come JPEG
Nome #
Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy 100
Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy 91
Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy 89
Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy 88
P-Wave Duration in Lead aVR and the Risk of Atrial Fibrillation in Hypertension. 86
Atrial natriuretic peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation 82
RyR2 common gene variant G1886S and the risk of ventricular arrhythmias in ICD patients with heart failure. 81
Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter-Defibrillator in Patients with Hypertrophic Cardiomyopathy. 79
Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter? 78
Osteopontin and Galectin-3 Predict the Risk of Ventricular Tachycardia and Fibrillation in Heart Failure Patients with Implantable Defibrillators. 68
Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool 67
Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome 66
Supraventricular arrhythmia with discordant electrocardiographic features. What is the arrhythmia mechanism? 64
Safety and efficacy of anti-tachycardia pacing in patients with hypertrophic cardiomyopathy implanted with an ICD 63
Premature ventricular extrastimulus without His or ventricular capture. An unexpected response during AV nodal reentrant tachycardia 63
An unusual pattern of Para-Hisian pacing. The role of infra-Hisian conduction delay 62
Autonomic cardiovascular control and cardiac arrhythmia in two pregnant women with hypertrophic cardiomyopathy: Insights from ICD monitoring 60
The subcutaneous implantable cardioverter-defibrillator. Current trends in clinical practice between guidelines and technology progress 59
Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator 57
Ventricular fibrillation undersensing due to air entrapment in a patient implanted with a subcutaneous cardioverter defibrillator 56
Gene variants of calcium handling proteins as a determinant of ventricular arrhythmias in ICD recipients with heart failure 50
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge 48
Calcium Handling Proteins Common Gene Variants And Risk Of Ventricular Arrhythmias In ICD Recipients With Heart Failure. 47
Calcium handling proteins gene variants and the risk of ventricular arrhythmias in ICD recipients with heart failure: focus on extremely opposing phenotypes 47
Common genetic variants in selected Ca2+ signaling genes and the risk of appropriate ICD interventions in patients with heart failure 43
Home delivery of the communicator for remote monitoring of cardiac implantable devices: a multicenter experience during the covid-19 lockdown 43
New oral anticoagulants in non-valvular atrial fibrillation. 39
Multi-modality imaging approach in a challenging case of surgically corrected partial anomalous pulmonary venous return and atrial tachycardia treated with radiofrequency ablation 37
Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique 37
Genetic deletion of the p66Shc adaptor protein protects against age-related cardiac arrhythmias. 30
Prevention of sudden cardiac death: focus on the subcutaneous implantable cardioverter-defibrillator 29
A mobile app for improving the compliance with remote management of patients with cardiac implantable devices. a multicenter evaluation in clinical practice 28
Substrates of scar-related ventricular arrhythmia in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study 22
Prognostic implications of non-sustained VT morphology in high-risk patients with HCM 17
Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy 14
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge 12
Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study 12
Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy 10
Assessing Atrial Fibrillation Substrates by P Wave Analysis. A Comprehensive Review 7
Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or a subcutaneous defibrillator 7
Prognostic implications of nonsustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathy 5
Totale 2.043
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020495 57 22 1 26 47 56 73 71 62 41 12 27
2020/2021139 6 28 2 1 1 4 2 7 22 34 20 12
2021/2022377 7 16 33 33 54 11 7 32 30 26 70 58
2022/2023370 61 82 14 16 42 34 9 26 46 4 19 17
2023/2024215 14 28 7 21 15 60 3 8 2 22 21 14
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 2.043